Beliefs about benefits and harms of medications and supplements for brain health.
Alzheimer’s disease
Dementia
Supplements
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
19
09
2019
revised:
03
01
2020
accepted:
23
01
2020
entrez:
6
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
The role of medications and supplements for brain health is a fast-changing and growing field, making it difficult for patients to receive updated and accurate information. The objective of this study was to assess patients' beliefs about the helpfulness or harmfulness of various medications and supplements on brain health. A convenience sample of adults from an integrated healthcare system completed a web-based survey. Descriptive statistics were used for this hypothesis-generating study. A total of 1661 respondents completed the survey. The majority of respondents were female (77%), between the ages of 51-70 (64%), and white (89%). Across the selected medications and supplements purported to improve a person's brain health (vitamin E, ginkgo biloba, hormones such as estrogen or testosterone, fish oil, and statins), 46-64% of respondents reported not knowing or skipped the item regarding their helpfulness to improve brain health. One out of four respondents reported benefits of vitamin E and nearly half reported benefits of fish oil on brain health; neither benefit is supported by current evidence. For the two medication classes evaluated for increasing dementia risk (proton pump inhibitors and anticholinergics used as sleep aids), 63-77% of respondents reported not knowing or skipped the item regarding their harmfulness to brain health. Survey respondents largely reported not knowing the potential benefits and harms of different medications and supplements for brain health. Improved health communication on pharmaceutical effects on dementia risk is greatly needed, and its development and dissemination should involve healthcare providers, patients, and media outlets.
Identifiants
pubmed: 32021765
doi: 10.1016/j.pmedr.2020.101060
pii: S2211-3355(20)30020-6
pii: 101060
pmc: PMC6995253
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101060Subventions
Organisme : NIA NIH HHS
ID : K76 AG059929
Pays : United States
Informations de copyright
© 2020 The Author(s).
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to report.
Références
J Health Commun. 2004 Sep-Oct;9(5):443-60; discussion 81-4
pubmed: 15513791
JAMA Neurol. 2016 Apr;73(4):410-6
pubmed: 26882076
JAMA Intern Med. 2016 Apr;176(4):473-82
pubmed: 26998708
AMIA Annu Symp Proc. 2018 Dec 05;2018:1036-1045
pubmed: 30815147
JAMA Intern Med. 2019 Jun 24;:null
pubmed: 31233095
Ann Intern Med. 2018 Jan 2;168(1):52-62
pubmed: 29255909
J Am Geriatr Soc. 2017 Sep;65(9):1969-1974
pubmed: 28590010
Ann Intern Med. 2018 Jan 2;168(1):39-51
pubmed: 29255847
J Alzheimers Dis. 2019;68(2):523-529
pubmed: 30814348
J Am Geriatr Soc. 2018 Feb;66(2):247-253
pubmed: 29134629
PLoS One. 2017 Feb 15;12(2):e0171006
pubmed: 28199356
Am J Health Behav. 2019 Mar 1;43(2):300-310
pubmed: 30808470
PLoS One. 2019 Jul 2;14(7):e0219213
pubmed: 31265473
Eur Arch Psychiatry Clin Neurosci. 2015 Aug;265(5):419-28
pubmed: 25341874
JAMA Neurol. 2017 Feb 1;74(2):225-232
pubmed: 27942728
J Am Geriatr Soc. 2018 Feb;66(2):224-226
pubmed: 29134626
JAMA. 2019 Feb 12;321(6):543-544
pubmed: 30681701
JAMA Intern Med. 2015 Mar;175(3):401-7
pubmed: 25621434
BMJ. 2018 Apr 25;361:k1315
pubmed: 29695481
J Health Commun. 2016;21(1):109-17
pubmed: 26312772
Comput Inform Nurs. 2013 Nov;31(11):547-53
pubmed: 23974574
Ann Intern Med. 2018 Jan 2;168(1):77-79
pubmed: 29255884